Sponsors / RGNX
RGNX

REGENXBIO Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
3Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)NCT03566043RGNXPhase 2, Phase 3Active not recruiting2023-11-27Actual
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142RGNXPhase 2, Phase 3Active not recruiting2026-09Estimated
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)NCT07236606RGNXPhase 3Active not recruiting2028-04-30Estimated

Latest recorded trial changes